{"title": "New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes", "author": "Emily Wasserman", "url": "https://www.fiercepharma.com/pharma/new-one-year-data-of-ideglira-shows-glucose-lowering-effect-was-maintained-for-people-type-2", "hostname": "fiercepharma.com", "description": "New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes San Francisco, U.S., 14 June 2014 - New Phase 3a findings show IDegLira, the... | New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes San Francisco, U.S., 14 June 2014 - New Phase 3a findings show IDegLira, the...", "sitename": "FiercePharma", "date": "2014-06-16", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}